About CanCOVID

CanCOVID was launched in April 2020 with funding from Innovation, Science and Economic Development Canada, and the support of Dr. Mona Nemer, the federal government’s Chief Science Advisor, in response to the COVID‑19 pandemic. In a matter of months, our organization brought together an extraordinary scientific and research community to collaborate via an online platform, and to rapidly produce and disseminate credible knowledge to help inform public health guidance during the COVID‑19 pandemic and post-pandemic future.

We are a strong, transdisciplinary, open science initiative, committed to giving the Government of Canada a line of sight on existing and emerging COVID‑19 science and research. We help connect the experts with the information for rapid COVID‑19 pandemic and post-pandemic impact/action. While we serve the research and policy community, we also value the patient partners, healthcare professionals, graduate trainees, and industry collaborators who are a part of our network and who help support the COVID‑19 pandemic and post-pandemic work.

Learn more about our executive leadership, Theme Leads, and Secretariat by touring this page.


Our purpose is to support the scientific effort and community in their work through encouraging multidisciplinary collaborations and helping to connect people and resources to enable rapid knowledge mobilization and science-to-policy action. We are also committed to helping to provide our government partners with a better line of sight to existing and emerging COVID‑19 science and research.

Executive Leadership

Peter Juni

Network Science Advisor

Peter Juni

Peter is the Director of the Applied Health Research Centre (AHRC) at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, holds a Tier 1 Canada Research Chair in Clinical Epidemiology of Chronic Diseases, and is a Professor at the Department of Medicine and the Institute of Health Policy, Management and Evaluation at the University of Toronto. He is a graduate of the Faculty of Medicine at the University of Bern in Switzerland, completed his training in internal medicine at various hospitals in Switzerland, and was a Research Fellow at the Department of Social Medicine at the University of Bristol, UK. Prior to joining St. Michael’s Hospital, Peter was the Director of the Institute of Primary Health Care and Professor of Primary Care and Clinical Epidemiology at the Faculty of Medicine at the University of Bern in Switzerland. He held previous appointments as Director of the Institute of Social and Preventive Medicine at the University of Bern and Founding Director of CTU Bern, the University’s clinical trials unit.

Peter is internationally renowned for his methodological work and for his clinical research on the management of cardiovascular and musculoskeletal disorders. A Fellow of the European Society of Cardiology, he has had leading roles in several major cardiovascular trials, including SIRTAX, LEADERS, FAME 2 and MATRIX, served as a member of several task forces of the European Society of Cardiology and co-authored the European guidelines on myocardial revascularization and on the management of acute myocardial infarction. Peter served as Editor of two Cochrane Review Groups, and contributed to the Cochrane Risk of bias tools for randomized and non-randomized studies. Since March 2020, he has worked nearly exclusively on clinical trials, observational studies, basic research, and science communication related to COVID-19. Additionally, he has served as Scientific Director of Ontario’s COVID‑19 Science Advisory Table since June 2020. Peter has contributed to over 500 papers, which have been cited more than 140,000 times.

Credentials: MD, FESC

Affiliations: Professor of Medicine and Epidemiology, Department of Medicine and Institute of Health Policy, Management and Evaluation, University of Toronto

Director, Applied Health Research Centre, Li Ka Shing Knowledge Institute, St. Michael’s Hospital

Nathan Stall

Network Science Advisor

Nathan Stall

Dr. Nathan Stall received his medical degree from Western University and completed his residency in Internal Medicine and fellowship training in Geriatric Medicine at the University of Toronto. He is currently a research fellow at Women‘s College Research Institute at Women’s College Hospital and is completing a PhD in Clinical Epidemiology & Health Care Research at the Institute of Health Policy, Management and Evaluation (IHPME) at the University of Toronto. His doctoral research uses large administrative databases to study the population health impact of caregiving for dementia. His other research interests include drug safety for older adults, sex and gender-based determinants of ageing, and health care utilization among persons with dementia. During the COVID‑19 pandemic, he has been actively involved in research modelling long-term care home outbreaks and the factors associated with outbreaks occurring and the spread of COVID‑19 throughout homes. His research is supported by the University of Toronto Department of Medicine’s Eliot Phillipson Clinician-Scientist Training Program and the Vanier Canada Graduate Scholarship. He has been a Staff Geriatrician at Sinai Health System since 2017. His clinical work focuses on acute care geriatrics. Dr. Stall attends on the inpatient Geriatric Medicine Consultation Service and on the Internal Medicine Clinical Teaching Units at Mount Sinai Hospital.

Affiliations: MD, PhD(c), FRCPC

Credentials: Geriatrics and Internal Medicine, Sinai Health and the University Health Network Hospitals Research Fellow, Women’s College Research Institute, Women’s College Hospital

PhD Candidate, Clinical Epidemiology & Health Care Research, Institute of Health Policy, Management and Evaluation, University of Toronto

Eliot Phillipson Clinician-Scientist Training Program and the Division of Geriatric Medicine, Department of Medicine, University of Toronto

Susan Law

Managing Director & Knowledge Mobilization Lead

Susan Law

Dr. Susan Law is the Managing Director & Knowledge Mobilization Lead for CanCOVID and a Senior Scientist at Trillium Health Partners – Institute of Better Health. She has a PhD from the London School of Hygiene & Tropical Medicine (LSHTM), University of London UK, a Master’s in Health Administration (University of Toronto), and a BSc in Human Kinetics from the University of Guelph. Dr. Law currently holds a position as Associate Professor at the University of Toronto – Institute for Health Policy, Management and Evaluation, and is an Adjunct Professor in the Department of Family Medicine at McGill University.

Dr. Law’s research career began in the UK at the University of Oxford where she participated in qualitative studies of the role of evidence in changing clinical practice. In Canada, she has worked as a senior scientist with Quebec health technology assessment agency, and with St. Mary’s Research Centre with an academic appointment as Associate Professor in the McGill Department of Family Medicine. Her research program focuses on personal experiences of illness, using qualitative methods and video recording of patient and family stories, and associated knowledge translation and applications for policy, education and patient and family-centered care. She is the director of the Canadian Health Experiences Research Network (www.healthexperiences.ca) as part of an international collaboration amongst 12 countries (www.dipexinternational.org).  

Karim Keshavjee

Health Informatics Advisor

Karim Keshavjee

Dr. Karim Keshavjee trained as a Family Physician and is the CEO of InfoClin, a company that provides health informatics consulting to a variety of organizations across North America. He has over 25 years of experience in health informatics.

Karim was the Project-Director for the COMPETE research program at McMaster University which studied the impact of clinical decision support on the care of patients with diabetes and vascular disease.

He has been a consultant to Canada Health Infoway for their pan-Canadian electronic prescribing project (CeRx) and their inter-operable electronic health record (iEHR) project.

Karim was the Clinical Data Architect and EMR Consultant for CPCSSN, Canada’s primary care chronic disease surveillance network. CPCSSN is a network of over 1200 physicians which provides access data on 1.7 million patients for research and surveillance.

Over the last decade, Karim has been working on researching how to improve mhealth apps and designing enabling environments for their use in the healthcare system. Karim has published several articles on mhealth apps in a variety of disease areas. He recently published a paper on how technology can support patient empowerment.

Karim’s current research is focused on how to use artificial intelligence and machine learning in the service of diabetes prevention through the PREVENT program.

Karim is an Assistant Professor, Teaching Stream and Program Director for the Health Informatics program at the University of Toronto and a Visiting Scholar at Ryerson University.

LinkedIn: https://www.linkedin.com/in/karimkeshavjee/

Pubmed: https://pubmed.ncbi.nlm.nih.gov/?term=karim+keshavjee

CanCOVID Science Advisors

CanCOVID is in the process of renewing its Secretariat and scientific advisors to align with our new mandate from our federal partners through to March 2023. We are currently recruiting a panel of Canadian experts from across a range of disciplines, locations, and backgrounds to provide scientific expertise and advice on a new program of work that will include a series of rapid evidence briefs and public panel sessions in response to federal priorities for COVID-related evidence and expert opinion. Stay tuned for an update very soon.


Shadi Niakan

Delivery Manager

Haris Lutvica

Ciara Kilbride Amaral

Kaitlin James

Christine Chan

Karen Palmer

With funding from the Government of Canada

Please complete this short survey to help us understand our impact. Thank you!

Give Feedback